Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. [electronic resource]
Producer: 20010802Description: 5432-40 p. digitalISSN:- 0008-5472
- Androgens -- physiology
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Arsenic Trioxide
- Arsenicals -- pharmacology
- Caspases -- metabolism
- Cell Death -- drug effects
- Cell Division -- drug effects
- Dose-Response Relationship, Drug
- Enzyme Activation -- drug effects
- Humans
- JNK Mitogen-Activated Protein Kinases
- MAP Kinase Kinase 4
- Male
- Mice
- Mice, Inbred BALB C
- Mice, SCID
- Mitogen-Activated Protein Kinase Kinases -- metabolism
- Mitogen-Activated Protein Kinases -- metabolism
- Neoplasm Metastasis -- pathology
- Neoplasm Transplantation
- Neoplastic Stem Cells -- drug effects
- Oxides -- pharmacology
- Prostatic Neoplasms -- drug therapy
- Reactive Oxygen Species -- metabolism
- Transplantation, Heterologous
- Tumor Cells, Cultured
- Tumor Stem Cell Assay
- Xenograft Model Antitumor Assays
- p38 Mitogen-Activated Protein Kinases
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.